Sore eyes significant vision-based indicator of COVID-19: BMJ
IANS Dec 10, 2020
In a fight against the novel Coronavirus, researchers, including one of Indian-origin, have revealed that sore eyes are the most significant vision-based indicator of COVID-19.
For our comprehensive coverage and latest updates on COVID-19 click here.
"This is the first study to investigate the various eye symptoms indicative of conjunctivitis in relation to COVID-19, their time frame in relation to other well-known COVID-19 symptoms and their duration," said study author Shahina Pardhan from the Anglia Ruskin University (ARU) in the UK. For the results, published in the BMJ Open Ophthalmology, the research team asked people who had a confirmed COVID-19 diagnosis to complete a questionnaire about their symptoms, and how those compared to before they tested positive.
The study found that sore eyes was significantly more common when the participants had COVID-19, with 16 percent reporting the issue as one of their symptoms. Just five percent reported having had the condition beforehand. While 18 percent of people reported suffering from photophobia (light sensitivity) as one of their symptoms, this was only a five percent increase from their pre-COVID-19 state. Of the 83 respondents, 81 percent reported ocular issues within two weeks of other COVID-19 symptoms. Of those, 80 percent reported their eye problems lasted less than two weeks.
The most common reported symptoms overall were fatigue (suffered by 90 percent of respondents), a fever (76 percent) and a dry cough (66 percent). "This study is important because it helps us understand more about how COVID-19 can infect the conjunctiva and how this then allows the virus to spread through the body," the study authors noted.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries